- Location
Coronary Stent System
"-
Promus Premier Coronary Stent System Has Obtained an Approval From The US FDA
Nov 27, 2013US-based Boston Scientific has obtained an approval from the US Food and Drug Administration (FDA) for its Promus PREMIER everolimus-eluting platinum chromium coronary stent system. The company's next-generation durable polymer ...
-
Biomedical Obtained CE Mark Approval for Its Pk Papyrus Covered Coronary Stent System
Nov 7, 2013Germany-based biomedical technology company Biotronik has obtained CE Mark approval for its PK Papyrus covered coronary stent system for use in the treatment of acute coronary artery perforation. According to Biotronik, the company's PK ...
Tags: Coronary Stent System, Medicine
-
Micell Has Received CE Mark Clearance for Its Mistent Ses
Jun 14, 2013Micell, a US-based biomedical company, has received CE (Conformité Européenne) Mark clearance for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES). MiStent Sirolimus Eluting Absorbable ...
Tags: Micell, Mistent SES
-
Two-Year Results From Excella BD Randomized Clinical Trial Was Announced by Elixir Medical
May 27, 2013US-based medical devices developer Elixir Medical has announced that the results of its CE Mark-approved DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer coating were outstanding. Its CE Mark-approved DESyne BD ...
-
MGuard Embolic Protection Stent Is Launched by InspireMD
Apr 25, 2013InspireMD has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to initiate MASTER II clinical study of its MGuard embolic protection stent (EPS). The CE-marked ...
Tags: InspireMD, Protection Stent Study
-
Abbott Has Obtained Regulatory Approval for Its Eluting Coronary Stent System
Jan 4, 2013Abbott has obtained regulatory approval for its XIENCE Xpedition Everolimus Eluting Coronary Stent system,designed for improving coronary artery luminal diameter in patients with symptomatic heart disease due to de novo native coronary ...
Tags: Abbott, FDA, Drug Eluting System, XIENCE, symptomatic heart disease
-
Svelte Medical Systems Has Treated The First Patient in The ACES Clinical Trial
Dec 31, 2012Svelte Medical Systems has treated the first patient in the ACES (Acrobat Coronary stent system effectiveness European Study) clinical trial. ACES is a randomized, controlled study to show the clinical benefit and utilization of the ...
Tags: Svelte Medical Systems, clinical trial, ACES, company news
-
The First Patient Has Been Treated by Svelte Medical Systems Aimed to Treat Diseases
Dec 25, 2012Svelte Medical Systems has treated the first patient in a randomized, controlled study using its fixed-wire based system, designed for treating patients with coronary artery lesions. The low profile Svelte Acrobat Integrated Delivery ...
Tags: Svelte Medical Systems, fixed wire based system, coronary artery lesions
-
Boston Scientific Has Obtained CE Mark Approval for Its Synergy Bioabsorbable
Dec 18, 2012Boston Scientific has obtained CE mark approval for its Synergy Everolimus-Eluting platinum chromium coronary stent system, designed to improve post-implant vessel healing. The coronary stent, which features a combination of ...
-
Abbott's Everolimus Eluting Coronary Stent System Has Been Accorded with CE Mark
Dec 18, 2012Global healthcare firm Abbott's everolimus eluting coronary stent system has been accorded with CE Mark in Europe. The XIENCE Xpedition everolimus eluting coronary stent system, which is used to treat coronary artery disease, provides ...
Tags: Abbott, CE mark, coronary stent system, coronary artery disease
-
Cardionovum Plans to Launch Its New Sirolimus-Eluting Coronary Stent System
Dec 17, 2012Cardionovum is planning to launch its new Sirolimus-eluting coronary stent system, Prolimus Biograde, in Q4 2012. The new Prolimus Biograde features thin-stent strut design of just 71 microns which is designed to provide uniform stent ...
Tags: Cardionovum, Sirolimus-eluting coronary stent system, clinical product
-
Elixir Gains CE Mark Approval for DESyne BD Novolimus Eluting Coronary Stent System
Dec 17, 2012Elixir Medical has gained CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer coating. The Elixir DESyne BD stent leverages the technology that enables an ultrathin (< 3 microns) polymer ...
Tags: Elixir Medical, Elixir DESyne BD stent, biodegradable polymer coating
-
Boston Scientific Receives FDA Approval for New Lengths of Promus Plus Stent System
Dec 17, 2012Boston Scientific has received the US Food and Drug Administration (FDA) approval for 32 mm and 38 mm lengths of the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent system. The Promus Element Stent is made with a ...
Tags: FDA, Boston Scientific, Promus Element Stent, coronary artery disease
-
Boston Scientific Has Completed Enrolling First Patient in a Evolve II Clinical
Dec 3, 2012Boston Scientific has completed enrolling first patient in a EVOLVE II clinical trial of its Synergy Everolimus-Eluting platinum chromium coronary stent system. The CE-marked stent features a combination of everolimus drug and ...
Tags: Synergy Everolimus Eluting platinum chromium coronary stent system
